What we do Aspira Pathlab & Diagnostics Ltd is a leading pathology and diagnostic services provider in India, operating diagnostic centers offering pathology and radiology investigations. |
Founded in 1,973 |
Market share Strong regional presence in Maharashtra with a loyal customer base and growing footprint. |
Problem solved Provides reliable and technologically advanced diagnostic testing to individuals and healthcare providers ensuring accurate health assessments. |
Top clients or who we serve Individual patients, hospitals, healthcare providers, and businesses primarily in Maharashtra, India (B2C and B2B). |
Key management Dr. Pankaj J Shah (Managing Director and CEO), Mr. Nikunj Mange (Executive Director). |
Our journey and innovations Incorporated in 1973, acquired Ankur Pathology in 2016, and adopted new tech like chatbots & patient engagement platforms to enhance services. |
Where we operate Pan-India presence with stronger operations in Maharashtra, India. |
Top products or what we offer Pathology investigation services, radiology investigations, and related healthcare services at diagnostic centers. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mostly recurring from diagnostic tests and services. |
Our industry position Emerging strong regional player with asset-light model and expanding technology driven service approach. |
Financial highlights FY 2024-25 revenue ₹22 Cr with net profit ₹2.02 Cr, showing profit turnaround from previous loss. |
Geographical revenue split Revenue primarily from India with significant concentration in Maharashtra. |
Order book - |
Whats driving growth Growth driven by technological adoption, expanding hospital partnerships, and enhancing patient engagement. |
Our future plans Focus on scaling operations, optimizing cost, expanding into new hospitals and diagnostic facilities, and technology integration. |
Our green promise - |
Our people and values Employs over 140 professionals focusing on patient-centric care and technology-driven processes. |
Key challenges ahead Managing high front-ended costs and optimizing payback period while scaling. |
Interesting facts Established in 1973, recently formed and later acquired assets of Aspira DNA Diagnostics Gujarat LLP. |
Risks and strategy Mitigating high cost risks with asset-light expansion and technology upgrades; focus on strengthening systems and customer experience. |
